I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Moluçon‐Chabrot, C.
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (5)
Languages
english (10)
french (3)
Sorted by: Relevance
Sorted by: Year
?
1
COMBINATION OF RITUXIMAB‐LENALIDOMIDE‐IBRUTINIB IN RELAPSED..:
Houillier, C
;
Moluçon‐Chabrot, C.
;
Moles, M.‐P.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
2
IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO‐R..:
Soussain, C.
;
Choquet, S.
;
Houillier, C.
...
Hematological Oncology. 35 (2017) S2 - p. 72-72 , 2017
Link:
https://doi.org/10.1002/..
?
3
Intérêt du dosage de l'haptoglobine pour juger de l'observa..:
Montagnon, P.Y.
;
Fan, A.
;
Chen Wa, C.
...
Revue du Rhumatisme. 90 (2023) - p. A120 , 2023
Link:
https://doi.org/10.1016/..
?
4
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C.
;
Choquet, S.
;
Blonski, M.
...
European Journal of Cancer. 117 (2019) - p. 121-130 , 2019
Link:
https://doi.org/10.1016/..
?
5
Lenalidomide in combination with intravenous rituximab (REV..:
Ghesquieres, H.
;
Chevrier, M.
;
Laadhari, M.
...
Annals of Oncology. 30 (2019) 4 - p. 621-628 , 2019
Link:
https://doi.org/10.1093/..
?
6
A phase 1/2 trial of lenalidomide and dexamethasone in adul..:
Tavernier-Tardy, E.
;
Cornillon, J.
;
Molucon-Chabrot, C.
...
Hematology. 22 (2016) 4 - p. 217-223 , 2016
Link:
https://doi.org/10.1080/..
?
7
Fasciite de Shulman et aplasie médullaire idiopathique : de..:
De Masson, A.
;
Bouaziz, J.-D.
;
Peffault de Latour, R.
...
Annales de Dermatologie et de Vénéréologie. 140 (2013) 12 - p. S605 , 2013
Link:
https://doi.org/10.1016/..
?
8
Une cause inhabituelle de paralysie faciale : la maladie de..:
Makarawiez, C.
;
Trouillier, S.
;
Delèvaux, I.
...
La Revue de Médecine Interne. 29 (2008) - p. S103-S104 , 2008
Link:
https://doi.org/10.1016/..
?
9
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C
;
Choquet, S
;
Blonski, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.05.024. , 2019
Link:
https://hal-univ-rennes1..
?
10
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C
;
Choquet, S
;
Blonski, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.05.024. , 2019
Link:
https://univ-rennes.hal...
?
11
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C
;
Choquet, S
;
Blonski, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.05.024. , 2019
Link:
https://univ-rennes.hal...
?
12
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C
;
Choquet, S
;
Blonski, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.05.024. , 2019
Link:
https://univ-rennes.hal...
?
13
Ibrutinib monotherapy for relapse or refractory primary CNS..:
Soussain, C
;
Choquet, S
;
Blonski, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.05.024. , 2019
Link:
https://univ-rennes.hal...
1-13
